Gossamer Bio, Inc., 2026-09-04
An SEC Form D private-offering notice from San Diego, CA, a $150,000,000 filer-stated offering target in Biotech. Filed 2026-09-04. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing seralutinib for pulmonary arterial hypertension and related lung diseases
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Labs Companies, Inc., 2026-09-04, $5B, Beverly Hills, CA
- Animal Biosciences, Inc., 2026-09-09, $2.6M, Boston, MA
- Verse Enterprises, Inc., 2026-09-04, $53.7M, San Francisco, CA
- Airway Therapeutics, Inc., 2026-09-09, $50.6M, Marietta, GA
- Nuvve Holding Corp., 2026-09-04, $14.7M, San Diego, CA
- Episteme Prognostics, Inc., 2026-09-04, $6M, Brooklyn, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.